Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

B. Casale, Thomas; T. Luskin, Allan; W. Busse, William; S. Zeiger, Robert; Trzaskoma, Benjamin; Yang, Ming; M. Griffin, Noelle; E. Chipps, Bradley

doi:10.1016/j.jaip.2018.04.043

Public

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Published in The Journal of Allergy and Clinical Immunology In Practice • May 22, 2018

Authors:

Thomas B. Casale

Allan T. Luskin

William W. Busse

Abstract

BACKGROUND: Omalizumab has demonstrated efficacy in clinical trials of patients with asthma, but real-world data are needed. OBJECTIVE: To assess outcomes after omalizumab initiation in patients with asthma in a real-world setting. METHODS: Patients aged 12 years and older with allergic asthma who w...

Subject

Omalizumab

Medicine

Exhaled nitric oxide

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!